{"transactions":[{"id":1000648,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":50218,"kind":"person","name":"Kiu Cu Seng","position":1,"cik":"0001891617","reported_name":"Kiu Cu Seng","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-13T23:00:02.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":1.4,"value":280000.0,"ownership":{"direct":true},"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001493152-25-022421","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225022421/ownership.xml","form_type":"4"}},{"id":1000647,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":50217,"kind":"person","name":"Doris Wong Sing Ee","position":1,"cik":"0001892421","reported_name":"Doris Wong Sing Ee","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-13T23:00:01.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":300178,"price":1.4,"value":420249.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"As adjusted for 1-for-16 reverse stock split on May 12, 2025 and 1-for-15 reverse stock split on July 7, 2025."}],"balance_after":1111131,"source":{"system":"sec-edgar","filing":"0001493152-25-022422","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225022422/ownership.xml","form_type":"4"}},{"id":1007047,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73588,"kind":"person","name":"Yap Kim Choy","position":1,"cik":"0002081554","reported_name":"Yap Kim Choy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Common Stock Warrants","published_at":"2025-11-05T23:00:05.000Z","date":"2025-11-05","kind":"other","planned":false,"acquired":false,"shares":31535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025."}],"balance_after":0,"derivative":{"exercise_price":10.2,"exercise_date":"2025-06-20","expiration_date":"2030-06-20","underlying":"Common Stock","underlying_shares":31535},"source":{"system":"sec-edgar","filing":"0001493152-25-020918","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225020918/ownership.xml","form_type":"4"}},{"id":1007046,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73588,"kind":"person","name":"Yap Kim Choy","position":1,"cik":"0002081554","reported_name":"Yap Kim Choy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Common Stock Warrants","published_at":"2025-11-05T23:00:05.000Z","date":"2025-11-05","kind":"other","planned":false,"acquired":false,"shares":218000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025."}],"balance_after":0,"derivative":{"exercise_price":9,"exercise_date":"2025-06-20","expiration_date":"2030-06-20","underlying":"Common Stock","underlying_shares":218000},"source":{"system":"sec-edgar","filing":"0001493152-25-020918","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225020918/ownership.xml","form_type":"4"}},{"id":1007045,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73588,"kind":"person","name":"Yap Kim Choy","position":1,"cik":"0002081554","reported_name":"Yap Kim Choy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Common Stock Warrants","published_at":"2025-11-05T23:00:05.000Z","date":"2025-11-05","kind":"other","planned":false,"acquired":false,"shares":218000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025."}],"balance_after":0,"derivative":{"exercise_price":7.65,"exercise_date":"2025-06-20","expiration_date":"2030-06-20","underlying":"Common Stock","underlying_shares":218000},"source":{"system":"sec-edgar","filing":"0001493152-25-020918","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225020918/ownership.xml","form_type":"4"}},{"id":1007044,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73588,"kind":"person","name":"Yap Kim Choy","position":1,"cik":"0002081554","reported_name":"Yap Kim Choy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-05T23:00:05.000Z","date":"2025-11-05","kind":"other","planned":false,"acquired":true,"shares":467535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025."}],"balance_after":467535,"source":{"system":"sec-edgar","filing":"0001493152-25-020918","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225020918/ownership.xml","form_type":"4"}},{"id":1007043,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73588,"kind":"person","name":"Yap Kim Choy","position":1,"cik":"0002081554","reported_name":"Yap Kim Choy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-05T23:00:05.000Z","date":"2025-11-05","kind":"sale","planned":false,"acquired":false,"shares":28540,"price":1.7,"value":48518.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-25-020918","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225020918/ownership.xml","form_type":"4"}},{"id":1007042,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73587,"kind":"person","name":"Kua Khai Loon","position":1,"cik":"0002081556","reported_name":"Kua Khai Loon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Common Stock Warrants","published_at":"2025-11-05T23:00:03.000Z","date":"2025-11-05","kind":"other","planned":false,"acquired":false,"shares":31535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025."}],"balance_after":0,"derivative":{"exercise_price":10.2,"exercise_date":"2025-06-20","expiration_date":"2030-06-20","underlying":"Common Stock","underlying_shares":31535},"source":{"system":"sec-edgar","filing":"0001493152-25-020919","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225020919/ownership.xml","form_type":"4"}},{"id":1007041,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73587,"kind":"person","name":"Kua Khai Loon","position":1,"cik":"0002081556","reported_name":"Kua Khai Loon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Common Stock Warrants","published_at":"2025-11-05T23:00:03.000Z","date":"2025-11-05","kind":"other","planned":false,"acquired":false,"shares":218000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025."}],"balance_after":0,"derivative":{"exercise_price":9,"exercise_date":"2025-06-20","expiration_date":"2030-06-20","underlying":"Common Stock","underlying_shares":218000},"source":{"system":"sec-edgar","filing":"0001493152-25-020919","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225020919/ownership.xml","form_type":"4"}},{"id":1007040,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73587,"kind":"person","name":"Kua Khai Loon","position":1,"cik":"0002081556","reported_name":"Kua Khai Loon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Common Stock Warrants","published_at":"2025-11-05T23:00:03.000Z","date":"2025-11-05","kind":"other","planned":false,"acquired":false,"shares":218000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025."}],"balance_after":0,"derivative":{"exercise_price":7.65,"exercise_date":"2025-06-20","expiration_date":"2030-06-20","underlying":"Common Stock","underlying_shares":218000},"source":{"system":"sec-edgar","filing":"0001493152-25-020919","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225020919/ownership.xml","form_type":"4"}},{"id":1007039,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73587,"kind":"person","name":"Kua Khai Loon","position":1,"cik":"0002081556","reported_name":"Kua Khai Loon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-05T23:00:03.000Z","date":"2025-11-05","kind":"other","planned":false,"acquired":true,"shares":467535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025."}],"balance_after":467535,"source":{"system":"sec-edgar","filing":"0001493152-25-020919","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225020919/ownership.xml","form_type":"4"}},{"id":1007038,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73586,"kind":"person","name":"Ong Yee Lung","position":1,"cik":"0002081473","reported_name":"Ong Yee Lung","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Common Stock Warrants","published_at":"2025-11-05T23:00:03.000Z","date":"2025-11-05","kind":"other","planned":false,"acquired":false,"shares":31535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025"}],"balance_after":0,"derivative":{"exercise_price":10.2,"exercise_date":"2025-06-20","expiration_date":"2030-06-20","underlying":"Common Stock","underlying_shares":31535},"source":{"system":"sec-edgar","filing":"0001493152-25-020917","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225020917/ownership.xml","form_type":"4"}},{"id":1007037,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73586,"kind":"person","name":"Ong Yee Lung","position":1,"cik":"0002081473","reported_name":"Ong Yee Lung","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Common Stock Warrants","published_at":"2025-11-05T23:00:03.000Z","date":"2025-11-05","kind":"other","planned":false,"acquired":false,"shares":218000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025"}],"balance_after":0,"derivative":{"exercise_price":9,"exercise_date":"2025-06-20","expiration_date":"2030-06-20","underlying":"Common Stock","underlying_shares":218000},"source":{"system":"sec-edgar","filing":"0001493152-25-020917","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225020917/ownership.xml","form_type":"4"}},{"id":1007036,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73586,"kind":"person","name":"Ong Yee Lung","position":1,"cik":"0002081473","reported_name":"Ong Yee Lung","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Common Stock Warrants","published_at":"2025-11-05T23:00:03.000Z","date":"2025-11-05","kind":"other","planned":false,"acquired":false,"shares":218000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025"}],"balance_after":0,"derivative":{"exercise_price":7.65,"exercise_date":"2025-06-20","expiration_date":"2030-06-20","underlying":"Common Stock","underlying_shares":218000},"source":{"system":"sec-edgar","filing":"0001493152-25-020917","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225020917/ownership.xml","form_type":"4"}},{"id":1007035,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73586,"kind":"person","name":"Ong Yee Lung","position":1,"cik":"0002081473","reported_name":"Ong Yee Lung","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-05T23:00:03.000Z","date":"2025-11-05","kind":"other","planned":false,"acquired":true,"shares":467535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person exchanged 218,000 Series A Common Stock Purchase Warrants, 218,000 Series B Common Stock Purchase Warrants and 31,535 Series C Common Stock Purchase Warrants for 467,535 shares of Common Stock pursuant to a warrant exchange agreement dated November 5, 2025"}],"balance_after":467535,"source":{"system":"sec-edgar","filing":"0001493152-25-020917","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225020917/ownership.xml","form_type":"4"}},{"id":1009822,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73588,"kind":"person","name":"Yap Kim Choy","position":1,"cik":"0002081554","reported_name":"Yap Kim Choy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T23:00:23.000Z","date":"2025-10-30","kind":"sale","planned":false,"acquired":false,"shares":112260,"price":1.807,"value":202853.82,"ownership":{"direct":true},"balance_after":28500,"source":{"system":"sec-edgar","filing":"0001493152-25-020647","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225020647/ownership.xml","form_type":"4"}},{"id":1009821,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73587,"kind":"person","name":"Kua Khai Loon","position":1,"cik":"0002081556","reported_name":"Kua Khai Loon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T23:00:05.000Z","date":"2025-10-30","kind":"sale","planned":false,"acquired":false,"shares":242477,"price":1.8,"value":436458.6,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-25-020645","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225020645/ownership.xml","form_type":"4"}},{"id":1009820,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73586,"kind":"person","name":"Ong Yee Lung","position":1,"cik":"0002081473","reported_name":"Ong Yee Lung","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T23:00:03.000Z","date":"2025-10-30","kind":"sale","planned":false,"acquired":false,"shares":248814,"price":1.8,"value":447865.2,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-25-020644","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225020644/ownership.xml","form_type":"4"}},{"id":1010837,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73588,"kind":"person","name":"Yap Kim Choy","position":1,"cik":"0002081554","reported_name":"Yap Kim Choy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-31T22:00:02.000Z","date":"2025-10-29","kind":"sale","planned":false,"acquired":false,"shares":110749,"price":1.834,"value":203113.666,"ownership":{"direct":true},"balance_after":140760,"source":{"system":"sec-edgar","filing":"0001493152-25-020479","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225020479/ownership.xml","form_type":"4"}},{"id":1011488,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73588,"kind":"person","name":"Yap Kim Choy","position":1,"cik":"0002081554","reported_name":"Yap Kim Choy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-30T22:00:09.000Z","date":"2025-10-28","kind":"sale","planned":false,"acquired":false,"shares":13111,"price":1.828,"value":23966.908,"ownership":{"direct":true},"balance_after":251509,"source":{"system":"sec-edgar","filing":"0001493152-25-020277","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225020277/ownership.xml","form_type":"4"}},{"id":1012194,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73588,"kind":"person","name":"Yap Kim Choy","position":1,"cik":"0002081554","reported_name":"Yap Kim Choy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-29T22:00:02.000Z","date":"2025-10-27","kind":"sale","planned":false,"acquired":false,"shares":120250,"price":2.118,"value":254689.5,"ownership":{"direct":true},"balance_after":264620,"source":{"system":"sec-edgar","filing":"0001493152-25-020109","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225020109/ownership.xml","form_type":"4"}},{"id":1012747,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73586,"kind":"person","name":"Ong Yee Lung","position":1,"cik":"0002081473","reported_name":"Ong Yee Lung","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-28T22:00:04.000Z","date":"2025-10-24","kind":"sale","planned":false,"acquired":false,"shares":19858,"price":1.99,"value":39517.42,"ownership":{"direct":true},"balance_after":248814,"source":{"system":"sec-edgar","filing":"0001493152-25-019929","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225019929/ownership.xml","form_type":"4"}},{"id":1012746,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73588,"kind":"person","name":"Yap Kim Choy","position":1,"cik":"0002081554","reported_name":"Yap Kim Choy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-28T22:00:02.000Z","date":"2025-10-24","kind":"sale","planned":false,"acquired":false,"shares":19595,"price":1.902,"value":37269.69,"ownership":{"direct":true},"balance_after":384870,"source":{"system":"sec-edgar","filing":"0001493152-25-019928","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225019928/ownership.xml","form_type":"4"}},{"id":1014310,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":74036,"kind":"person","name":"FITTERS Diversified Berhad","position":1,"cik":"0002086215","reported_name":"FITTERS Diversified Berhad","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-23T22:00:02.000Z","date":"2025-10-21","kind":"sale","planned":false,"acquired":false,"shares":92352,"price":3.005,"value":277517.76,"ownership":{"direct":true},"balance_after":279248,"source":{"system":"sec-edgar","filing":"0001493152-25-019139","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225019139/ownership.xml","form_type":"4"}},{"id":1014928,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":74036,"kind":"person","name":"FITTERS Diversified Berhad","position":1,"cik":"0002086215","reported_name":"FITTERS Diversified Berhad","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-22T22:00:02.000Z","date":"2025-10-20","kind":"sale","planned":false,"acquired":false,"shares":108107,"price":3.088,"value":333834.416,"ownership":{"direct":true},"balance_after":371600,"source":{"system":"sec-edgar","filing":"0001493152-25-018963","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225018963/ownership.xml","form_type":"4"}},{"id":1015947,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73587,"kind":"person","name":"Kua Khai Loon","position":1,"cik":"0002081556","reported_name":"Kua Khai Loon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-20T22:00:04.000Z","date":"2025-10-16","kind":"sale","planned":false,"acquired":false,"shares":88204,"price":4.217,"value":371956.268,"ownership":{"direct":true},"balance_after":242477,"source":{"system":"sec-edgar","filing":"0001493152-25-018694","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225018694/ownership.xml","form_type":"4"}},{"id":1015946,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73587,"kind":"person","name":"Kua Khai Loon","position":1,"cik":"0002081556","reported_name":"Kua Khai Loon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-20T22:00:04.000Z","date":"2025-10-15","kind":"sale","planned":false,"acquired":false,"shares":7479,"price":5.661,"value":42338.619,"ownership":{"direct":true},"balance_after":330681,"source":{"system":"sec-edgar","filing":"0001493152-25-018694","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225018694/ownership.xml","form_type":"4"}},{"id":1015945,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":74036,"kind":"person","name":"FITTERS Diversified Berhad","position":1,"cik":"0002086215","reported_name":"FITTERS Diversified Berhad","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-20T22:00:02.000Z","date":"2025-10-16","kind":"sale","planned":false,"acquired":false,"shares":26051,"price":5.5,"value":143280.5,"ownership":{"direct":true},"balance_after":479707,"source":{"system":"sec-edgar","filing":"0001493152-25-018693","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225018693/ownership.xml","form_type":"4"}},{"id":1017773,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73586,"kind":"person","name":"Ong Yee Lung","position":1,"cik":"0002081473","reported_name":"Ong Yee Lung","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-16T22:00:02.000Z","date":"2025-10-14","kind":"sale","planned":false,"acquired":false,"shares":135793,"price":6,"value":814758.0,"ownership":{"direct":true},"balance_after":268672,"source":{"system":"sec-edgar","filing":"0001493152-25-018350","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225018350/ownership.xml","form_type":"4"}},{"id":1019558,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":74036,"kind":"person","name":"FITTERS Diversified Berhad","position":1,"cik":"0002086215","reported_name":"FITTERS Diversified Berhad","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-14T22:00:04.000Z","date":"2025-10-10","kind":"sale","planned":false,"acquired":false,"shares":51400,"price":5.258,"value":270261.2,"ownership":{"direct":true},"balance_after":505758,"source":{"system":"sec-edgar","filing":"0001493152-25-018069","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225018069/ownership.xml","form_type":"4"}},{"id":1020437,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73587,"kind":"person","name":"Kua Khai Loon","position":1,"cik":"0002081556","reported_name":"Kua Khai Loon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-10T22:17:51.000Z","date":"2025-09-16","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":5.132,"value":128300.0,"ownership":{"direct":true},"balance_after":338160,"source":{"system":"sec-edgar","filing":"0001493152-25-017832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225017832/ownership.xml","form_type":"4"}},{"id":1020436,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73587,"kind":"person","name":"Kua Khai Loon","position":1,"cik":"0002081556","reported_name":"Kua Khai Loon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-10T22:17:51.000Z","date":"2025-09-12","kind":"sale","planned":false,"acquired":false,"shares":22251,"price":6.224,"value":138490.224,"ownership":{"direct":true},"balance_after":363160,"source":{"system":"sec-edgar","filing":"0001493152-25-017832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225017832/ownership.xml","form_type":"4"}},{"id":1020435,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":74036,"kind":"person","name":"FITTERS Diversified Berhad","position":1,"cik":"0002086215","reported_name":"FITTERS Diversified Berhad","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-10T22:16:21.000Z","date":"2025-10-08","kind":"sale","planned":false,"acquired":false,"shares":142000,"price":5.293,"value":751606.0,"ownership":{"direct":true},"balance_after":557158,"source":{"system":"sec-edgar","filing":"0001493152-25-017830","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225017830/ownership.xml","form_type":"4"}},{"id":1044243,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73587,"kind":"person","name":"Kua Khai Loon","position":1,"cik":"0002081556","reported_name":"Kua Khai Loon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-10T19:09:51.000Z","date":"2025-09-05","kind":"sale","planned":false,"acquired":false,"shares":19054,"price":7.01,"value":133568.54,"ownership":{"direct":true},"balance_after":385411,"source":{"system":"sec-edgar","filing":"0001493152-25-012981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000149315225012981/ownership.xml","form_type":"4"}},{"id":1048340,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73588,"kind":"person","name":"Yap Kim Choy","position":1,"cik":"0002081554","reported_name":"Yap Kim Choy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Common Stock Warrants","published_at":"2025-09-04T20:00:19.000Z","date":"2025-09-04","kind":"other","planned":false,"acquired":false,"shares":186465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person exchanged 186,465 Series C Common Stock Purchase Warrants for 186,465 shares of Common Stock pursuant to a warrant exchange agreement dated September 4, 2025."}],"balance_after":31535,"derivative":{"exercise_price":10.2,"exercise_date":"2025-06-20","expiration_date":"2030-06-20","underlying":"Common Stock","underlying_shares":186465},"source":{"system":"sec-edgar","filing":"0001641172-25-026573","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000164117225026573/ownership.xml","form_type":"4"}},{"id":1048339,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73588,"kind":"person","name":"Yap Kim Choy","position":1,"cik":"0002081554","reported_name":"Yap Kim Choy","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T20:00:19.000Z","date":"2025-09-04","kind":"other","planned":false,"acquired":true,"shares":186465,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person exchanged 186,465 Series C Common Stock Purchase Warrants for 186,465 shares of Common Stock pursuant to a warrant exchange agreement dated September 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person exchanged 186,465 Series C Common Stock Purchase Warrants for 186,465 shares of Common Stock pursuant to a warrant exchange agreement dated September 4, 2025."}],"balance_after":404465,"source":{"system":"sec-edgar","filing":"0001641172-25-026573","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000164117225026573/ownership.xml","form_type":"4"}},{"id":1048336,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73587,"kind":"person","name":"Kua Khai Loon","position":1,"cik":"0002081556","reported_name":"Kua Khai Loon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Common Stock Warrants","published_at":"2025-09-04T20:00:17.000Z","date":"2025-09-04","kind":"other","planned":false,"acquired":false,"shares":186465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person exchanged 186,465 Series C Common Stock Purchase Warrants for 186,465 shares of Common Stock pursuant to a warrant exchange agreement"}],"balance_after":31535,"derivative":{"exercise_price":10.2,"exercise_date":"2025-06-20","expiration_date":"2030-06-20","underlying":"Common Stock","underlying_shares":186465},"source":{"system":"sec-edgar","filing":"0001641172-25-026574","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000164117225026574/ownership.xml","form_type":"4"}},{"id":1048335,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73587,"kind":"person","name":"Kua Khai Loon","position":1,"cik":"0002081556","reported_name":"Kua Khai Loon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T20:00:17.000Z","date":"2025-09-04","kind":"other","planned":false,"acquired":true,"shares":186465,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person exchanged 186,465 Series C Common Stock Purchase Warrants for 186,465 shares of Common Stock pursuant to a warrant exchange agreement"},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person exchanged 186,465 Series C Common Stock Purchase Warrants for 186,465 shares of Common Stock pursuant to a warrant exchange agreement"}],"balance_after":404465,"source":{"system":"sec-edgar","filing":"0001641172-25-026574","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000164117225026574/ownership.xml","form_type":"4"}},{"id":1048338,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73586,"kind":"person","name":"Ong Yee Lung","position":1,"cik":"0002081473","reported_name":"Ong Yee Lung","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Common Stock Warrants","published_at":"2025-09-04T20:00:15.000Z","date":"2025-09-04","kind":"other","planned":false,"acquired":false,"shares":186465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person exchanged 186,465 Series C Common Stock Purchase Warrants for 186,465 shares of Common Stock pursuant to a warrant exchange agreement dated September 4, 2025."}],"balance_after":31535,"derivative":{"exercise_price":10.2,"exercise_date":"2025-06-20","expiration_date":"2030-06-20","underlying":"Common Stock","underlying_shares":186465},"source":{"system":"sec-edgar","filing":"0001641172-25-026572","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000164117225026572/ownership.xml","form_type":"4"}},{"id":1048337,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":73586,"kind":"person","name":"Ong Yee Lung","position":1,"cik":"0002081473","reported_name":"Ong Yee Lung","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T20:00:15.000Z","date":"2025-09-04","kind":"other","planned":false,"acquired":true,"shares":186465,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting Person exchanged 186,465 Series C Common Stock Purchase Warrants for 186,465 shares of Common Stock pursuant to a warrant exchange agreement dated September 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person exchanged 186,465 Series C Common Stock Purchase Warrants for 186,465 shares of Common Stock pursuant to a warrant exchange agreement dated September 4, 2025."}],"balance_after":404465,"source":{"system":"sec-edgar","filing":"0001641172-25-026572","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000164117225026572/ownership.xml","form_type":"4"}},{"id":1076534,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":25480,"kind":"person","name":"Lazar David E.","position":1,"cik":"0001932843","reported_name":"Lazar David E.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-04T23:23:01.000Z","date":"2025-07-30","kind":"sale","planned":false,"acquired":false,"shares":6750,"price":12.36,"value":83430.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number Shares owned by the Reporting Person is reflective of a 1-for-15 reverse stock split effected by the Issuer on July 7, 2025 (the \"Reverse Stock Split\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Due to an inadvertent ministerial error, the Form 4 filed by the Reporting Person on February 28, 2025 reported beneficial ownership of 354,738 shares of the Issuer's Series D Convertible Preferred Stock which had already been converted into 162,588 shares of Common Stock (after giving effect to the Reverse Stock Split) as of such date."}],"balance_after":155838,"source":{"system":"sec-edgar","filing":"0000921895-25-002082","document":"form412227019_08042025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000092189525002082/form412227019_08042025.xml","form_type":"4"}},{"id":1238986,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":24574,"kind":"person","name":"NATAN DAVID","position":1,"cik":"0001253108","reported_name":"NATAN DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2025-02-28T21:48:59.000Z","date":"2025-02-26","kind":"grant","planned":false,"acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 26, 2025 (the \"Grant Date\"), the Reporting Person was granted 700,000 Non-Qualified Stock Options to purchased shares of common stock (the \"Common Stock\") of Cyclacel Pharmaceuticals, Inc. (the \"Company\") in consideration of his services as a director of the Company. The option grant became exercisable on the Grant Date."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes shares of Common Stock previously reported in Table I of the Reporting Person's Form 4 filed on January 7, 2025, which were not issued by the Company and are being replaced with the option grant reported in this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 26, 2025 (the \"Grant Date\"), the Reporting Person was granted 700,000 Non-Qualified Stock Options to purchased shares of common stock (the \"Common Stock\") of Cyclacel Pharmaceuticals, Inc. (the \"Company\") in consideration of his services as a director of the Company. The option grant became exercisable on the Grant Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 26, 2025 (the \"Grant Date\"), the Reporting Person was granted 700,000 Non-Qualified Stock Options to purchased shares of common stock (the \"Common Stock\") of Cyclacel Pharmaceuticals, Inc. (the \"Company\") in consideration of his services as a director of the Company. The option grant became exercisable on the Grant Date."}],"balance_after":700000,"derivative":{"exercise_price":0.33,"exercise_date":"2025-02-26","expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0000921895-25-000652","document":"form412227019nat_02282025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000092189525000652/form412227019nat_02282025.xml","form_type":"4"}},{"id":1238984,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":25480,"kind":"person","name":"Lazar David E.","position":1,"cik":"0001932843","reported_name":"Lazar David E.","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Interim CEO"}}],"security":"Series D Convertible Preferred Stock","published_at":"2025-02-28T21:48:15.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":false,"shares":1745262,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The shares of Series D Preferred Stock are convertible at the option of the Reporting Person for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"At a closing on February 6, 2025, the Reporting Person acquired 2,100,000 shares of Series D Preferred Stock from the Company for a total purchase price of $2,100,000. Each share of Series D Preferred Stock is convertible into 110 shares of the Company's Common Stock at any time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The Series D Preferred Stock is exercisable immediately upon issuance, is perpetual and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The Series D Preferred Stock is exercisable immediately upon issuance, is perpetual and has no expiration date."}],"balance_after":354738,"derivative":{"underlying":"Common Stock","underlying_shares":191978820},"source":{"system":"sec-edgar","filing":"0000921895-25-000651","document":"form412227019laz_02282025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000092189525000651/form412227019laz_02282025.xml","form_type":"4"}},{"id":1238983,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":25480,"kind":"person","name":"Lazar David E.","position":1,"cik":"0001932843","reported_name":"Lazar David E.","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Interim CEO"}}],"security":"Series C Convertible Preferred Stock","published_at":"2025-02-28T21:48:15.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The shares of Series C Preferred Stock are convertible at the option of the Reporting Person for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"At a closing on January 6, 2025, the Reporting Person acquired 1,000,000 shares of Series C Preferred Stock from the Company for a total purchase price of $1,000,000. Each share of Series C Preferred Stock is convertible into 2.65 shares of the Company's Common Stock at any time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Series C Preferred Stock is exercisable immediately upon issuance, is perpetual and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series C Preferred Stock is exercisable immediately upon issuance, is perpetual and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2650000},"source":{"system":"sec-edgar","filing":"0000921895-25-000651","document":"form412227019laz_02282025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000092189525000651/form412227019laz_02282025.xml","form_type":"4"}},{"id":1238982,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":25480,"kind":"person","name":"Lazar David E.","position":1,"cik":"0001932843","reported_name":"Lazar David E.","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2025-02-28T21:48:15.000Z","date":"2025-02-26","kind":"sale","planned":false,"acquired":false,"shares":194628820,"price":0.0283,"value":5507995.606,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"On February 26, 2025, the Reporting Person sold 194,628,820 shares of Common Stock in a private transaction for total consideration of $5,500,000."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On February 26, 2025, the Reporting Person sold 194,628,820 shares of Common Stock in a private transaction for total consideration of $5,500,000."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000921895-25-000651","document":"form412227019laz_02282025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000092189525000651/form412227019laz_02282025.xml","form_type":"4"}},{"id":1238981,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":25480,"kind":"person","name":"Lazar David E.","position":1,"cik":"0001932843","reported_name":"Lazar David E.","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2025-02-28T21:48:15.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":true,"shares":191978820,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares represent the conversion of 1,745,262 shares of the Company's Series D Convertible Preferred Stock (the \"Series D Preferred Stock\") owned by the Reporting Person into shares of Common Stock of the Company."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares of Series D Preferred Stock are convertible at the option of the Reporting Person for no additional consideration."}],"balance_after":194628820,"source":{"system":"sec-edgar","filing":"0000921895-25-000651","document":"form412227019laz_02282025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000092189525000651/form412227019laz_02282025.xml","form_type":"4"}},{"id":1238980,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":25480,"kind":"person","name":"Lazar David E.","position":1,"cik":"0001932843","reported_name":"Lazar David E.","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2025-02-28T21:48:15.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":true,"shares":2650000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent the conversion of 1,000,000 shares of the Series C Convertible Preferred Stock (the \"Series C Preferred Stock\") of Cyclacel Pharmaceuticals, Inc. (the \"Company\") owned by the Reporting Person into shares of the Company's common stock, par value $0.001 per share (the \"Common Stock\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of Series C Preferred Stock are convertible at the option of the Reporting Person for no additional consideration."}],"balance_after":2650000,"source":{"system":"sec-edgar","filing":"0000921895-25-000651","document":"form412227019laz_02282025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000092189525000651/form412227019laz_02282025.xml","form_type":"4"}},{"id":1238985,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":25914,"kind":"person","name":"Ben-Tzvi Avraham","position":1,"cik":"0001944721","reported_name":"Ben-Tzvi Avraham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2025-02-28T21:47:32.000Z","date":"2025-02-26","kind":"grant","planned":false,"acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 26, 2025 (the \"Grant Date\"), the Reporting Person was granted 700,000 Non-Qualified Stock Options to purchased shares of common stock (the \"Common Stock\") of Cyclacel Pharmaceuticals, Inc. (the \"Company\") in consideration of his services as a director of the Company. The option grant became exercisable on the Grant Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 26, 2025 (the \"Grant Date\"), the Reporting Person was granted 700,000 Non-Qualified Stock Options to purchased shares of common stock (the \"Common Stock\") of Cyclacel Pharmaceuticals, Inc. (the \"Company\") in consideration of his services as a director of the Company. The option grant became exercisable on the Grant Date."}],"balance_after":700000,"derivative":{"exercise_price":0.33,"exercise_date":"2025-02-26","expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0000921895-25-000650","document":"form412227019ben_02282025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000092189525000650/form412227019ben_02282025.xml","form_type":"4"}},{"id":1277015,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":25480,"kind":"person","name":"Lazar David E.","position":1,"cik":"0001932843","reported_name":"Lazar David E.","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Interim CEO"}}],"security":"Series D Convertible Preferred Stock","published_at":"2025-02-10T22:45:48.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":2100000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"At a closing on February 6, 2025, the Reporting Person acquired 2,100,000 shares of Series D Preferred Stock for a total purchase price of $2,100,000. Each share of Series D Preferred Stock is convertible into 110 shares of the Company's Common Stock at any time."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The shares of Series D Preferred Stock are convertible at the option of the Reporting Person for no additional consideration."},{"field":"date","element":"transactionDate","label":"F4","text":"At a closing on February 6, 2025, the Reporting Person acquired 2,100,000 shares of Series D Preferred Stock for a total purchase price of $2,100,000. Each share of Series D Preferred Stock is convertible into 110 shares of the Company's Common Stock at any time."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At a closing on February 6, 2025, the Reporting Person acquired 2,100,000 shares of Series D Preferred Stock for a total purchase price of $2,100,000. Each share of Series D Preferred Stock is convertible into 110 shares of the Company's Common Stock at any time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series D Preferred Stock is perpetual and therefore has no expiration date."}],"balance_after":2100000,"derivative":{"exercise_date":"2025-02-06","underlying":"Common Stock","underlying_shares":231000000},"source":{"system":"sec-edgar","filing":"0000921895-25-000312","document":"form412227001cycc_02102025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000092189525000312/form412227001cycc_02102025.xml","form_type":"4"}},{"id":1308507,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":24574,"kind":"person","name":"NATAN DAVID","position":1,"cik":"0001253108","reported_name":"NATAN DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-08T00:07:52.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of restricted stock issued pursuant to a Director Agreement dated as of January 2, 2025 by and between Cyclacel Pharmaceuticals, Inc. and David Natan."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0000921895-25-000087","document":"form412227001_01072025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000092189525000087/form412227001_01072025.xml","form_type":"4"}},{"id":1665405,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-31T21:56:01.000Z","date":"2024-01-29","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Dr. Schwartz in connection with his appointment as interim Chief Medical Officer of Cyclacel Pharmaceuticals, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the option vest in equal monthly installments beginning on February 29, 2024, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":12500,"derivative":{"exercise_price":2.28,"expiration_date":"2034-01-29","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001104659-24-008862","document":"tm244773-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465924008862/tm244773-1_4seq1.xml","form_type":"4"}},{"id":1665404,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-31T21:56:01.000Z","date":"2024-01-29","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal monthly installments beginning on February 29, 2024, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Dr. Schwartz in connection with his appointment as interim Chief Medical Officer of Cyclacel Pharmaceuticals, Inc."}],"balance_after":15205,"source":{"system":"sec-edgar","filing":"0001104659-24-008862","document":"tm244773-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465924008862/tm244773-1_4seq1.xml","form_type":"4"}},{"id":1700341,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95850,"kind":"person","name":"McBarron Paul","position":1,"cik":"0001357397","reported_name":"McBarron Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Warrants (right to buy)","published_at":"2023-12-26T21:05:25.000Z","date":"2023-12-21","kind":"purchase","planned":false,"acquired":true,"shares":1886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of common stock was purchased with an accompanying warrant at an aggregate purchase price of $3.315 per share and accompanying warrant."}],"balance_after":1886,"derivative":{"exercise_price":3.19,"exercise_date":"2023-12-21","expiration_date":"2030-12-21","underlying":"Common Stock","underlying_shares":1886},"source":{"system":"sec-edgar","filing":"0001104659-23-129186","document":"tm2333679-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923129186/tm2333679-1_4seq1.xml","form_type":"4"}},{"id":1700340,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95850,"kind":"person","name":"McBarron Paul","position":1,"cik":"0001357397","reported_name":"McBarron Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-12-26T21:05:25.000Z","date":"2023-12-21","kind":"purchase","planned":false,"acquired":true,"shares":1886,"price":3.315,"value":6252.09,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Reporting Person purchased unregistered shares of the Issuer's common stock in a private placement, pursuant to a Securities Purchase Agreement between the Reporting Person and the Issuer."}],"balance_after":33378,"source":{"system":"sec-edgar","filing":"0001104659-23-129186","document":"tm2333679-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923129186/tm2333679-1_4seq1.xml","form_type":"4"}},{"id":1700339,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95849,"kind":"person","name":"Rombotis Spiro George","position":1,"cik":"0001357396","reported_name":"Rombotis Spiro George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Warrants (right to buy)","published_at":"2023-12-26T21:05:23.000Z","date":"2023-12-21","kind":"purchase","planned":false,"acquired":true,"shares":6070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of common stock was purchased with an accompanying warrant at an aggregate purchase price of $3.315 per share and accompanying warrant."}],"balance_after":6070,"derivative":{"exercise_price":3.19,"exercise_date":"2023-12-21","expiration_date":"2030-12-21","underlying":"Common Stock","underlying_shares":6070},"source":{"system":"sec-edgar","filing":"0001104659-23-129185","document":"tm2333679-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923129185/tm2333679-2_4seq1.xml","form_type":"4"}},{"id":1700338,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95849,"kind":"person","name":"Rombotis Spiro George","position":1,"cik":"0001357396","reported_name":"Rombotis Spiro George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-12-26T21:05:23.000Z","date":"2023-12-21","kind":"purchase","planned":false,"acquired":true,"shares":6070,"price":3.315,"value":20122.05,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Reporting Person purchased unregistered shares of the Issuer's common stock in a private placement, pursuant to a Securities Purchase Agreement between the Reporting Person and the Issuer."}],"balance_after":68658,"source":{"system":"sec-edgar","filing":"0001104659-23-129185","document":"tm2333679-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923129185/tm2333679-2_4seq1.xml","form_type":"4"}},{"id":1839976,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95849,"kind":"person","name":"Rombotis Spiro George","position":1,"cik":"0001357396","reported_name":"Rombotis Spiro George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2023-07-03T20:58:13.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person received an award of 110,000 options on June 30, 2023, which shall vest in full on June 30, 2026, provided, however, that if certain clinical milestones are achieved then such options shall vest in full earlier in connection with such achievement."}],"balance_after":110000,"derivative":{"exercise_price":0.5891,"exercise_date":"2024-06-30","expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001104659-23-077661","document":"tm2320411-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077661/tm2320411-9_4seq1.xml","form_type":"4"}},{"id":1839975,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-03T20:57:54.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":42438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":42438,"derivative":{"exercise_price":0.5891,"exercise_date":"2024-06-30","expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":42438},"source":{"system":"sec-edgar","filing":"0001104659-23-077660","document":"tm2320411-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077660/tm2320411-8_4seq1.xml","form_type":"4"}},{"id":1839974,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-03T20:57:54.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":21219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 21,219 restricted stock units on June 30, 2023, which shall vest in full on June 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":40415,"source":{"system":"sec-edgar","filing":"0001104659-23-077660","document":"tm2320411-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077660/tm2320411-8_4seq1.xml","form_type":"4"}},{"id":1839973,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":34255,"kind":"person","name":"Spiegel Robert J.","position":1,"cik":"0001492256","reported_name":"Spiegel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-03T20:57:33.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":42438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Dr. Spiegel for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":42438,"derivative":{"exercise_price":0.5891,"exercise_date":"2024-06-30","expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":42438},"source":{"system":"sec-edgar","filing":"0001104659-23-077658","document":"tm2320411-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077658/tm2320411-7_4seq1.xml","form_type":"4"}},{"id":1839972,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":34255,"kind":"person","name":"Spiegel Robert J.","position":1,"cik":"0001492256","reported_name":"Spiegel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-03T20:57:33.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":21219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 21,219 restricted stock units on June 30, 2023, which shall vest in full on June 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Dr. Spiegel for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":39415,"source":{"system":"sec-edgar","filing":"0001104659-23-077658","document":"tm2320411-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077658/tm2320411-7_4seq1.xml","form_type":"4"}},{"id":1839971,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95850,"kind":"person","name":"McBarron Paul","position":1,"cik":"0001357397","reported_name":"McBarron Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2023-07-03T20:57:11.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":70200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person received an award of 70,200 options on June 30, 2023, which shall vest in full on June 30, 2026, provided, however, that if certain clinical milestones are achieved then such options shall vest in full earlier in connection with such achievement."}],"balance_after":70200,"derivative":{"exercise_price":0.5891,"exercise_date":"2024-06-30","expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":70200},"source":{"system":"sec-edgar","filing":"0001104659-23-077657","document":"tm2320411-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077657/tm2320411-6_4seq1.xml","form_type":"4"}},{"id":1839970,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111705,"kind":"person","name":"Kirschbaum Mark","position":1,"cik":"0001830211","reported_name":"Kirschbaum Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-07-03T20:56:52.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":70200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person received an award of 70,200 options on June 30, 2023, which shall vest in full on June 30, 2026, provided, however, that if certain clinical milestones are achieved then such options shall vest in full earlier in connection with such achievement."}],"balance_after":70200,"derivative":{"exercise_price":0.5891,"exercise_date":"2026-06-30","expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":70200},"source":{"system":"sec-edgar","filing":"0001104659-23-077656","document":"tm2320411-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077656/tm2320411-5_4seq1.xml","form_type":"4"}},{"id":1839969,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":27704,"kind":"person","name":"Walker Karin L","position":1,"cik":"0001559422","reported_name":"Walker Karin L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-03T20:56:33.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":42438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Ms. Walker for her services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":42438,"derivative":{"exercise_price":0.5891,"exercise_date":"2024-06-30","expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":42438},"source":{"system":"sec-edgar","filing":"0001104659-23-077655","document":"tm2320411-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077655/tm2320411-4_4seq1.xml","form_type":"4"}},{"id":1839968,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":27704,"kind":"person","name":"Walker Karin L","position":1,"cik":"0001559422","reported_name":"Walker Karin L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-03T20:56:33.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":21219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 21,219 restricted stock units on June 30, 2023, which shall vest in full on June 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Ms. Walker for her services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":40602,"source":{"system":"sec-edgar","filing":"0001104659-23-077655","document":"tm2320411-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077655/tm2320411-4_4seq1.xml","form_type":"4"}},{"id":1839965,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111703,"kind":"person","name":"Ferguson Kenneth M.","position":1,"cik":"0001934344","reported_name":"Ferguson Kenneth M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-03T20:56:12.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":42438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Dr. Ferguson for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":42438,"derivative":{"exercise_price":0.5891,"exercise_date":"2024-06-30","expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":42438},"source":{"system":"sec-edgar","filing":"0001104659-23-077652","document":"tm2320411-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077652/tm2320411-3_4seq1.xml","form_type":"4"}},{"id":1839964,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111703,"kind":"person","name":"Ferguson Kenneth M.","position":1,"cik":"0001934344","reported_name":"Ferguson Kenneth M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-03T20:56:12.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":21219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 21,219 restricted stock units on June 30, 2023, which shall vest in full on June 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Dr. Ferguson for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":44952,"source":{"system":"sec-edgar","filing":"0001104659-23-077652","document":"tm2320411-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077652/tm2320411-3_4seq1.xml","form_type":"4"}},{"id":1839967,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-03T20:55:45.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":42438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Dr. Henney for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":42438,"derivative":{"exercise_price":0.5891,"exercise_date":"2024-06-30","expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":42438},"source":{"system":"sec-edgar","filing":"0001104659-23-077651","document":"tm2320411-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077651/tm2320411-2_4seq1.xml","form_type":"4"}},{"id":1839966,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-03T20:55:45.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":21219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 21,219 restricted stock units on June 30, 2023, which shall vest in full on June 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Dr. Henney for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":39415,"source":{"system":"sec-edgar","filing":"0001104659-23-077651","document":"tm2320411-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077651/tm2320411-2_4seq1.xml","form_type":"4"}},{"id":1839963,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-03T20:55:19.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":42438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Dr. Schwartz for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":42438,"derivative":{"exercise_price":0.5891,"exercise_date":"2024-06-30","expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":42438},"source":{"system":"sec-edgar","filing":"0001104659-23-077650","document":"tm2320411-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077650/tm2320411-1_4seq1.xml","form_type":"4"}},{"id":1839962,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-03T20:55:19.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":21219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 21,219 restricted stock units on June 30, 2023, which shall vest in full on June 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Dr. Schwartz for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":40602,"source":{"system":"sec-edgar","filing":"0001104659-23-077650","document":"tm2320411-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077650/tm2320411-1_4seq1.xml","form_type":"4"}},{"id":2036693,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95850,"kind":"person","name":"McBarron Paul","position":1,"cik":"0001357397","reported_name":"McBarron Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-02-02T21:19:39.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":31200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 31,200 restricted stock units on January 31, 2023, which shall vest in full on January 31, 2026, provided, however, that if certain clinical milestones are achieved then such restricted stock units shall vest in full earlier in connection with such achievement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 292 shares of common stock and 31,200 restricted stock units."}],"balance_after":31492,"source":{"system":"sec-edgar","filing":"0001104659-23-009914","document":"tm235262-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923009914/tm235262-3_4seq1.xml","form_type":"4"}},{"id":2036692,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95849,"kind":"person","name":"Rombotis Spiro George","position":1,"cik":"0001357396","reported_name":"Rombotis Spiro George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-02T21:18:24.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":57600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 57,600 restricted stock units on January 31, 2023, which shall vest in full on January 31, 2026, provided, however, that if certain clinical milestones are achieved then such restricted stock units shall vest in full earlier in connection with such achievement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,988 shares of common stock and 57,600 restricted stock units."}],"balance_after":62588,"source":{"system":"sec-edgar","filing":"0001104659-23-009910","document":"tm235262-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923009910/tm235262-2_4seq1.xml","form_type":"4"}},{"id":2036691,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111705,"kind":"person","name":"Kirschbaum Mark","position":1,"cik":"0001830211","reported_name":"Kirschbaum Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-02T21:17:17.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":31200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 31,200 restricted stock units on January 31, 2023, which shall vest in full on January 31, 2026, provided, however, that if certain clinical milestones are achieved then such restricted stock units shall vest in full earlier in connection with such achievement."}],"balance_after":31200,"source":{"system":"sec-edgar","filing":"0001104659-23-009908","document":"tm235262-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923009908/tm235262-1_4seq1.xml","form_type":"4"}},{"id":2228438,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111703,"kind":"person","name":"Ferguson Kenneth M.","position":1,"cik":"0001934344","reported_name":"Ferguson Kenneth M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T20:06:07.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":47467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option will vest and become exercisable in equal monthly installments for thirty-six months beginning on the date of the grant, which is June 14, 2022, subject to the Reporting Person continuing to provide services to the Issuer through each such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"These options were granted to Mr. Ferguson for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":47467,"derivative":{"exercise_price":1.11,"exercise_date":"2023-06-14","expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":47467},"source":{"system":"sec-edgar","filing":"0001104659-22-072381","document":"tm2218810-1_4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922072381/tm2218810-1_4a.xml","form_type":"4/A","original_submission_date":"2022-06-16"}},{"id":2228437,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111703,"kind":"person","name":"Ferguson Kenneth M.","position":1,"cik":"0001934344","reported_name":"Ferguson Kenneth M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T20:06:07.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":23733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 23,733 restricted stock units on June 14, 2022, which shall vest in three equal installments on June 14, 2023, June 14, 2024, and June 14, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"This Form 4 is being amended to correct a typographical error in the number of restricted stock units granted to the Reporting Person on June 14, 2022. 23,733 shares of restricted stock units were granted to the Reporting Person."}],"balance_after":23733,"source":{"system":"sec-edgar","filing":"0001104659-22-072381","document":"tm2218810-1_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922072381/tm2218810-1_4a.xml","form_type":"4/A","original_submission_date":"2022-06-16"}},{"id":2230361,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111703,"kind":"person","name":"Ferguson Kenneth M.","position":1,"cik":"0001934344","reported_name":"Ferguson Kenneth M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T20:39:27.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":47467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option will vest and become exercisable in equal monthly installments for thirty-six months beginning on the date of the grant, which is June 14, 2022, subject to the Reporting Person continuing to provide services to the Issuer through each such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These options were granted to Mr. Ferguson for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":47467,"derivative":{"exercise_price":1.11,"exercise_date":"2023-06-14","expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":47467},"source":{"system":"sec-edgar","filing":"0001104659-22-071945","document":"tm2218645d8_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922071945/tm2218645d8_4.xml","form_type":"4"}},{"id":2230360,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111703,"kind":"person","name":"Ferguson Kenneth M.","position":1,"cik":"0001934344","reported_name":"Ferguson Kenneth M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T20:39:27.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":27733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person received an award of 27,733 restricted stock units on June 14, 2022, which shall vest in three equal installments on June 14, 2023, June 14, 2024, and June 14, 2025."}],"balance_after":27733,"source":{"system":"sec-edgar","filing":"0001104659-22-071945","document":"tm2218645d8_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922071945/tm2218645d8_4.xml","form_type":"4"}},{"id":2230359,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":27704,"kind":"person","name":"Walker Karin L","position":1,"cik":"0001559422","reported_name":"Walker Karin L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T20:13:12.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":31645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options were granted to Ms. Walker for her services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":31645,"derivative":{"exercise_price":1.11,"exercise_date":"2023-06-14","expiration_date":"2032-06-14","underlying":"Common stock","underlying_shares":31645},"source":{"system":"sec-edgar","filing":"0001104659-22-071903","document":"tm2218645-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922071903/tm2218645-6_4seq1.xml","form_type":"4"}},{"id":2230358,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":27704,"kind":"person","name":"Walker Karin L","position":1,"cik":"0001559422","reported_name":"Walker Karin L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T20:13:12.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":15822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 15,822 restricted stock units on June 14, 2022, which shall vest in full on June 14, 2023."}],"balance_after":19383,"source":{"system":"sec-edgar","filing":"0001104659-22-071903","document":"tm2218645-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922071903/tm2218645-6_4seq1.xml","form_type":"4"}},{"id":2230357,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":34255,"kind":"person","name":"Spiegel Robert J.","position":1,"cik":"0001492256","reported_name":"Spiegel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T20:12:06.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":31645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options were granted to Dr. Spiegel for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":31645,"derivative":{"exercise_price":1.11,"exercise_date":"2023-06-14","expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":31645},"source":{"system":"sec-edgar","filing":"0001104659-22-071900","document":"tm2218645-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922071900/tm2218645-5_4seq1.xml","form_type":"4"}},{"id":2230356,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":34255,"kind":"person","name":"Spiegel Robert J.","position":1,"cik":"0001492256","reported_name":"Spiegel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T20:12:06.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":15822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 15,822 restricted stock units on June 14, 2022, which shall vest in full on June 14, 2023."}],"balance_after":18196,"source":{"system":"sec-edgar","filing":"0001104659-22-071900","document":"tm2218645-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922071900/tm2218645-5_4seq1.xml","form_type":"4"}},{"id":2230355,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":126107,"kind":"person","name":"Sems Lloyd","position":1,"cik":"0001436850","reported_name":"Sems Lloyd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T20:11:53.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":31645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options were granted to Mr. Sems for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":31645,"derivative":{"exercise_price":1.11,"exercise_date":"2023-06-14","expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":31645},"source":{"system":"sec-edgar","filing":"0001104659-22-071898","document":"tm2218645-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922071898/tm2218645-4_4seq1.xml","form_type":"4"}},{"id":2230354,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":126107,"kind":"person","name":"Sems Lloyd","position":1,"cik":"0001436850","reported_name":"Sems Lloyd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T20:11:53.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":15822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 15,822 restricted stock units on June 14, 2022, which shall vest in full on June 14, 2023."}],"balance_after":18196,"source":{"system":"sec-edgar","filing":"0001104659-22-071898","document":"tm2218645-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922071898/tm2218645-4_4seq1.xml","form_type":"4"}},{"id":2230353,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T20:11:49.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":31645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options were granted to Dr. Schwartz for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":31645,"derivative":{"exercise_price":1.11,"exercise_date":"2023-06-14","expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":31645},"source":{"system":"sec-edgar","filing":"0001104659-22-071895","document":"tm2218645-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922071895/tm2218645-3_4seq1.xml","form_type":"4"}},{"id":2230352,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":94776,"kind":"person","name":"SCHWARTZ BRIAN","position":1,"cik":"0001431322","reported_name":"SCHWARTZ BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T20:11:49.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":15822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 15,822 restricted stock units on June 14, 2022, which shall vest in full on June 14, 2023."}],"balance_after":19383,"source":{"system":"sec-edgar","filing":"0001104659-22-071895","document":"tm2218645-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922071895/tm2218645-3_4seq1.xml","form_type":"4"}},{"id":2230349,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T20:11:09.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":31645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options were granted to Dr. Henney for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":31645,"derivative":{"exercise_price":1.11,"exercise_date":"2023-06-14","expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":31645},"source":{"system":"sec-edgar","filing":"0001104659-22-071893","document":"tm2218645-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922071893/tm2218645-2_4seq1.xml","form_type":"4"}},{"id":2230348,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111704,"kind":"person","name":"HENNEY CHRISTOPHER S","position":1,"cik":"0001242880","reported_name":"HENNEY CHRISTOPHER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T20:11:09.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":15822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 15,822 restricted stock units on June 14, 2022, which shall vest in full on June 14, 2023."}],"balance_after":18196,"source":{"system":"sec-edgar","filing":"0001104659-22-071893","document":"tm2218645-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922071893/tm2218645-2_4seq1.xml","form_type":"4"}},{"id":2230351,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T20:10:40.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":31645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":31645,"derivative":{"exercise_price":1.11,"exercise_date":"2023-06-14","expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":31645},"source":{"system":"sec-edgar","filing":"0001104659-22-071892","document":"tm2218645-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922071892/tm2218645-1_4seq1.xml","form_type":"4"}},{"id":2230350,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T20:10:40.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":15822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 15,822 restricted stock units on June 14, 2022, which shall vest in full on June 14, 2023."}],"balance_after":19196,"source":{"system":"sec-edgar","filing":"0001104659-22-071892","document":"tm2218645-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922071892/tm2218645-1_4seq1.xml","form_type":"4"}},{"id":2470261,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95849,"kind":"person","name":"Rombotis Spiro George","position":1,"cik":"0001357396","reported_name":"Rombotis Spiro George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-16T21:16:22.000Z","date":"2021-12-13","kind":"grant","acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted as part of the Issuer's annual compensation review to executive officers."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"This Form 4 is being amended to correct a typographical error in the number of shares of Common Stock underlying the options granted to the reporting person on December 13, 2021. 190,000 shares of Common Stock underlie the granted options."}],"balance_after":190000,"derivative":{"exercise_price":3.45,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001104659-21-150527","document":"tm2135616d1_4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921150527/tm2135616d1_4a.xml","form_type":"4/A","original_submission_date":"2021-12-15"}},{"id":2472021,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95849,"kind":"person","name":"Rombotis Spiro George","position":1,"cik":"0001357396","reported_name":"Rombotis Spiro George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-15T21:20:03.000Z","date":"2021-12-13","kind":"grant","acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted as part of the Issuer's annual compensation review to executive officers."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis."}],"balance_after":190000,"derivative":{"exercise_price":3.45,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001104659-21-150003","document":"tm2135363d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921150003/tm2135363d3_4.xml","form_type":"4"}},{"id":2472073,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95850,"kind":"person","name":"McBarron Paul","position":1,"cik":"0001357397","reported_name":"McBarron Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-15T21:19:10.000Z","date":"2021-12-13","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted as part of the Issuer's annual compensation review to executive officers."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis."}],"balance_after":100000,"derivative":{"exercise_price":3.45,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-21-150001","document":"tm2135363d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921150001/tm2135363d2_4.xml","form_type":"4"}},{"id":2472020,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":111705,"kind":"person","name":"Kirschbaum Mark","position":1,"cik":"0001830211","reported_name":"Kirschbaum Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-15T21:18:49.000Z","date":"2021-12-13","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted as part of the Issuer's annual compensation review to executive officers."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis."}],"balance_after":100000,"derivative":{"exercise_price":3.45,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-21-150000","document":"tm2135363d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921150000/tm2135363d1_4.xml","form_type":"4"}},{"id":2489292,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-02T21:07:27.000Z","date":"2021-11-30","kind":"sale","acquired":false,"shares":12,"price":3.5716,"value":42.8592,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person sold 12 shares of common stock on November 30, 2021."}],"balance_after":3374,"source":{"system":"sec-edgar","filing":"0001104659-21-145913","document":"tm2134438-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921145913/tm2134438-1_4seq1.xml","form_type":"4"}},{"id":2501234,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":95849,"kind":"person","name":"Rombotis Spiro George","position":1,"cik":"0001357396","reported_name":"Rombotis Spiro George","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-22T21:05:55.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":4000,"price":4.5,"value":18000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person purchased 4,000 shares of common stock on November 18, 2021."}],"balance_after":4988,"source":{"system":"sec-edgar","filing":"0001104659-21-142474","document":"tm2133647-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921142474/tm2133647-1_4seq1.xml","form_type":"4"}},{"id":2591141,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-25T20:16:27.000Z","date":"2021-08-24","kind":"purchase","acquired":true,"shares":1000,"price":5,"value":5000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person purchased 1,000 shares of common stock on August 24, 2021."}],"balance_after":3386,"source":{"system":"sec-edgar","filing":"0001104659-21-109337","document":"tm2125937-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921109337/tm2125937-1_4seq1.xml","form_type":"4"}},{"id":2664339,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":138146,"kind":"person","name":"Hradsky Gregory T.","position":1,"cik":"0001439092","reported_name":"Hradsky Gregory T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T20:09:12.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":4748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options were granted to Mr. Hradsky for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":4748,"derivative":{"exercise_price":6.69,"exercise_date":"2022-06-15","expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":4748},"source":{"system":"sec-edgar","filing":"0001104659-21-082605","document":"tm2119990d7_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921082605/tm2119990d7_4.xml","form_type":"4"}},{"id":2664338,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":138146,"kind":"person","name":"Hradsky Gregory T.","position":1,"cik":"0001439092","reported_name":"Hradsky Gregory T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T20:09:12.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":2374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 2,374 restricted stock units on June 15, 2021, which shall vest in full on June 15, 2022."}],"balance_after":2374,"source":{"system":"sec-edgar","filing":"0001104659-21-082605","document":"tm2119990d7_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921082605/tm2119990d7_4.xml","form_type":"4"}},{"id":2664337,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":126107,"kind":"person","name":"Sems Lloyd","position":1,"cik":"0001436850","reported_name":"Sems Lloyd","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T20:08:30.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":4748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options were granted to Mr. Sems for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":4748,"derivative":{"exercise_price":6.69,"exercise_date":"2022-06-15","expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":4748},"source":{"system":"sec-edgar","filing":"0001104659-21-082600","document":"tm2119990d4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921082600/tm2119990d4_4.xml","form_type":"4"}}],"next_cursor":"2021-06-17T20:08:30.000000Z,2664337"}